SC 13D FILING

Company

ClearPoint Neuro, Inc.

Filed

June 5, 2017

Accession Number

0001534424-17-000252

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →